LINC00200

Across TCGA pan-cancer cohorts, LINC00200 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC00200’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC00200 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00200 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

LIHC, KIRC, and COAD are the cancer types where LINC00200 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00200 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.101	.046	1	view →
KIRC	All	All	−0.063	.023	1	view →
COAD	Male	All	−0.062	.042	1	view →
READ	All	II,III,IV	−0.020	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC00200–LIHC

Open the LIHC breakdown →